Global Neuromyelitis Optica Drug Market Data Survey Report 2025
- HEY1541240
- 80 Pages
- August 2017
- Pharmaceuticals
Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes pain in the eye and vision loss, and transverse myelitis, which causes weakness, numbness, and sometimes paralysis of the arms and legs, along with sensory disturbances and loss of bladder and bowel control. NMO leads to loss of myelin, which is a fatty substance that surrounds nerve fibers and helps nerve signals, move from cell to cell. The syndrome can also damage nerve fibers and leave areas of broken-down tissue. In the disease process of NMO, for reasons that aren't yet clear, immune system cells and antibodies attack and destroy myelin cells in the optic nerves and the spinal cord.Neuromyelitis optica drug is drug used in the treatment of neuromyelitis optica, in this report we focused on Glucocorticoids such as Methylprednisolone and Immunoglobulin such as IVIg.
The global Neuromyelitis Optica Drug market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Pfizer
FRESENIUS
TEVA
SANDOZ
Intas
Gyjtrs
NANG KUANG
Tianjin Kingyork
Baxter
CSL
Grifols
Octapharma
CBOP
Major applications as follows:
Acute attack
Remission prophylactic treatment
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Pfizer
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 FRESENIUS
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 TEVA
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 SANDOZ
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Intas
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Gyjtrs
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 NANG KUANG
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Tianjin Kingyork
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Baxter
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.10 CSL
3.10.1 Company Information
3.10.2 Product Specifications
3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.11 Grifols
3.12 Octapharma
3.13 CBOP
4 Major Application
4.1 Acute attack
4.1.1 Overview
4.1.2 Acute attack Market Size and Forecast
4.2 Remission prophylactic treatment
4.2.1 Overview
4.2.2 Remission prophylactic treatment Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of FRESENIUS
Tab Sales Revenue, Volume, Price, Cost and Margin of TEVA
Tab Sales Revenue, Volume, Price, Cost and Margin of SANDOZ
Tab Sales Revenue, Volume, Price, Cost and Margin of Intas
Tab Sales Revenue, Volume, Price, Cost and Margin of Gyjtrs
Tab Sales Revenue, Volume, Price, Cost and Margin of NANG KUANG
Tab Sales Revenue, Volume, Price, Cost and Margin of Tianjin Kingyork
Tab Sales Revenue, Volume, Price, Cost and Margin of Baxter
Tab Sales Revenue, Volume, Price, Cost and Margin of CSL
Tab Sales Revenue, Volume, Price, Cost and Margin of Grifols
Tab Sales Revenue, Volume, Price, Cost and Margin of Octapharma
Tab Sales Revenue, Volume, Price, Cost and Margin of CBOP
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Neuromyelitis Optica Drug Market Size and CAGR 2011-2017 (Value)
Fig Global Neuromyelitis Optica Drug Market Size and CAGR 2011-2017 (Volume)
Fig Global Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Value)
Fig Global Neuromyelitis Optica Drug Market Forecast and CAGR 2018-2025 (Volume)
Fig Acute attack Market Size and CAGR 2011-2017 (Value)
Fig Acute attack Market Size and CAGR 2011-2017 (Volume)
Fig Acute attack Market Forecast and CAGR 2018-2025 (Value)
Fig Acute attack Market Forecast and CAGR 2018-2025 (Volume)
Fig Remission prophylactic treatment Market Size and CAGR 2011-2017 (Value)
Fig Remission prophylactic treatment Market Size and CAGR 2011-2017 (Volume)
Fig Remission prophylactic treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Remission prophylactic treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
